Direct-to-Patient Digitaling Market Report 2025

The direct-to-patient digitaling market size has grown rapidly in recent years. It will grow from $3.37 billion in 2024 to $3.97 billion in 2025 at a compound annual growth rate (CAGR) of 17.8%. The growth during the historic period is driven by the increasing role of social media in patient engagement, rising digital literacy among patients, the growing influence of big data on healthcare decision-making, greater acceptance of direct-to-patient communication by pharmaceutical companies, and the expanding integration of digital tools into clinical workflows.

The direct-to-patient digitaling market size is expected to see rapid growth in the next few years. It will grow to $7.54 billion in 2029 at a compound annual growth rate (CAGR) of 17.4%. The growth during the forecast period is supported by the increasing need for real-time access to health data, the rise of healthcare consumerism, growing investments and funding in digital health, expansion of healthcare infrastructure in emerging markets, and greater emphasis on digital solutions for mental health. Key trends in the forecast period include advancements in wearable health technologies, integration of omnichannel patient communication, improvements in cybersecurity for digital health platforms, development of automated adherence tracking, and enhanced use of big data for predictive health insights.

The increasing emphasis on adopting patient-focused care models is contributing to the expansion of the direct-to-patient digital market. These care models emphasize addressing individual patient needs, respecting their preferences, and encouraging their active role in managing their own health. The shift toward this approach is driven by the goal of enhancing patient engagement, allowing individuals to take part in healthcare decisions that affect their well-being. Direct-to-patient digital solutions support these models by delivering tailored, convenient, and real-time healthcare services directly to individuals, giving them greater control over their treatment and health management. For example, in April 2025, Intuition Labs, a United States-based organization, reported that 80 percent of Americans support remote patient monitoring, with clinician usage increasing to 81 percent in 2023, marking a 305 percent rise. This increasing support for patient-focused care models is fueling the growth of the direct-to-patient digital market.

Leading companies in the direct-to-patient digital space are developing innovative solutions such as fully integrated digital experiences that aim to improve the entire healthcare journey and build stronger connections between patients and care providers. An end-to-end digital experience ensures a smooth, connected process across all stages of care, from initial interaction through to treatment and ongoing support. It brings together services such as virtual consultations, electronic prescriptions, and digital assistance into one cohesive system, promoting personalization, convenience, and efficiency. In January 2024, Eli Lilly and Company, a pharmaceutical firm based in the United States, launched LillyDirect, a comprehensive digital health platform. This platform connects individuals with medical care, prescription access, and support services through a single digital interface. It is intended to improve accessibility and provide customized treatment choices, while also simplifying how patients obtain medications and reducing obstacles to care. Continuous digital support through the platform also encourages ongoing patient involvement and better adherence to treatment plans.

In September 2024, Health Union LLC, a digital health company based in the United States, acquired Adfire Health LLC for an undisclosed sum. The purpose of this acquisition is to enhance Health Union's ability to engage with patients by incorporating Adfire Health’s knowledge in healthcare communication and marketing. Adfire Health LLC, also based in the United States, offers specialized services in direct-to-patient digital marketing aimed at improving how healthcare information and services reach individuals.

Major players in the direct-to-patient digitaling market are Google LLC, OMRON Healthcare Co. Ltd., 1Life Healthcare Inc. (One Medical), Hims & Hers Health Inc., Cerebral Inc., American Well Corporation, Lyra Health Inc., MDLIVE Inc., Ro Inc., Doctor On Demand Inc., Spring Care Inc., Withings Health Solutions, HealthJoy LLC, Zocdoc Inc., Calm.com Inc., Ada Health GmbH, K Health Inc., MeMD Inc., Sesame Inc., PlushCare Inc.

North America was the largest region in the direct-to-patient digitaling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in direct-to-patient digitaling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the direct-to-patient digitaling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Direct-to-patient digitaling involves using digital technologies and platforms to provide healthcare services, information, and therapies directly to patients, bypassing traditional intermediaries such as clinics or pharmacies. It includes tools such as mobile applications, telehealth services, wearable devices, and personalized digital engagement solutions to improve patient care, adherence, and outcomes. This model gives patients convenient, real-time access to healthcare resources along with data-driven support.

The primary health areas for direct-to-patient digitaling include chronic conditions, preventive health, and mental health. Chronic conditions are long-term medical disorders that require continuous management, including diabetes, cardiovascular diseases, respiratory illnesses, cancer, and arthritis. Psychographic factors cover lifestyles, values and beliefs, and personality traits. Technology factors involve device preferences, technical skills, and preferred communication methods. Behavioral factors include usage patterns, benefits sought, and loyalty status. These solutions are applied across various demographics, including different age groups, genders, and income levels.

The direct-to-patient digitaling market research report is one of a series of new reports that provides direct-to-patient digitaling market statistics, including the direct-to-patient digitaling industry global market size, regional shares, competitors with the direct-to-patient digitaling market share, detailed direct-to-patient digitaling market segments, market trends, and opportunities, and any further data you may need to thrive in the direct-to-patient digitaling industry. This direct-to-patient digitaling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The direct-to-patient digitaling market consists of revenues earned by entities by providing services such as teleconsultation services, therapy management services, and data analytics and personalized health insights. The market value includes the value of related goods sold by the service provider or included within the service offering. The direct-to-patient digitaling market also includes sales of at-home testing and diagnostic products, virtual rehabilitation and therapy products, and patient engagement and reward products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.